{
  "name" : "zero.sci-hub.se_6280_b2afdd0bbda9cd18fad6995e2365296c_chen2017.pdf",
  "metadata" : {
    "source" : "META",
    "title" : "Two-dimensional Pd-based nanomaterials for bioapplications",
    "authors" : [ "Xiaolan Chen", "Saige Shi", "Jingping Wei", "Mei Chen", "Nanfeng Zheng" ],
    "emails" : [ "chenxl@xmu.edu.cn;", "nfzheng@xmu.edu.cn.", "Pd@Au,", "Pd@Ag" ],
    "sections" : [ {
      "heading" : null,
      "text" : "Noble metal nanomaterials have been extensively explored in cancer diagnostic and therapeutic applications owing to their unique physical and chemical properties, such as facile synthesis, straightforward surface functionalization, strong photothermal effect, and excellent biocompatibility. Herein, we summarize the recent development of two-dimensional (2D) Pd-based nanomaterials and their applications in cancer diagnosis and therapy. Different synthetic strategies for Pd nanosheets and the related nanostructures, including Pd@Au, Pd@Ag nanoplates and mesocrystalline Pd nanocorolla, are first discussed. Together with their unique properties, the potential bioapplications of these 2D Pd nanomaterials are then demonstrated. With strong absorption in near-infrared (NIR) region, these nanomaterials have great potentials in cancer photothermal therapy (PTT). They also readily act as contrast agents in photoacoustic (PA) imaging or X-ray computed tomography (CT) to achieve imageguided cancer therapy. Moreover, significant efforts have been devoted to studying\nthe combination of PTT and other treatment modalities (e.g., chemotherapy or photodynamic therapy) based on Pd nanomaterials. The remarkable synergistic or collaborative effects to achieve better therapeutic efficacy are discussed as well. Additionally, the biosafety of 2D Pd-based nanomaterials in vitro and in vivo was evaluated. Finally, challenges for the applications of Pd-based nanomaterials in cancer diagnosis and therapy, and future research prospects are highlighted.\nKeywords 2D nanomaterials · Palladium · Optical properties · Bioimaging · Photothermal therapy · Combination therapy"
    }, {
      "heading" : "1 Introduction",
      "text" : "With the development of nanotechnology, the application of nanomaterials for drug delivery, cancer diagnosis and therapy has attracted great attention [1]. Especially two-dimensional (2D) nanomaterials with unique properties originated from their atomically thin thickness and 2D morphology features have been extensively studied in recent years [2-8]. For example, graphene and some transition metal dichalcogenides (e.g., MoS2 and Bi2Se3) with high surface area, strong near-infrared (NIR) light absorption and good biocompatibility have been applied to photothermal therapy and other biomedical fields [2-4, 6, 7].\nPhotothermal therapy (PTT), in which light energy is converted into thermal energy by light-absorbing agents for destroying cancer cells, has recently emerged as a new candidate technique for cancer treatment [9-15]. In particular, NIR laser-induced PTT has attracted increasing attention because of the deep tissue penetrating nature of NIR irradiation [16, 17]. A prerequisite for the development of NIR laser-induced PTT is to acquire biocompatible and efficient photothermal agents. Currently several types of NIR absorbing photothermal agents, including the organic compounds (e.g., indocyanine green (ICG) dye) [18-21], carbon-based nanomaterials (e.g., graphene oxide (GO) and carbon nanotubes) [22-26], metal nanostructures (e.g., Au or Pdbased nanomaterials) [27-38], copper chalcogenide semiconductors [39-42] and transition metal dichalcogenides mentioned above [6, 7], have been explored for photothermal ablation of cancer. Despite intense research interest in using these nanomaterials for PTT, several challenges still remain. For instance, the difficulty in adjusting the shape and size of NIR-absorbing nanomaterials makes systematical\ninvestigation of their bio-behaviors impossible and thus limits their clinical applications [33, 43]. Therefore, the development of NIR photothermal agents with well-defined morphologies and sizes, as well as good photothermal properties for cancer therapy, has aroused great research interest.\nLately, two-dimensional (2D) Pd nanosheets (NSs) have been regarded as a new kind of promising photothermal agents. They exhibit the following unique features: (1) the diameter of uniform Pd NSs is highly tunable in a wide range from sub-5 nm to 120 nm with fixed thickness, 1.8 nm, by changing the synthetic conditions. Moreover, other noble metals, such as Au and Ag, can be readily grown on the surface of Pd NSs to prepare 2D core-shell noble metal nanoplates with various thicknesses. By contrast, it is extremely challenging to synthesize other 2D nanostructures (e.g., like graphene, Bi2Se3 and MoS2) with well-defined thickness and diameter. (2) 2D Pd-based nanomaterials with different sizes exhibit strong absorption in the NIR region and also give high photothermal conversion efficiency. For example, a photothermal conversion efficiency of 52.0% at 808 nm was observed on\nPd NSs with diameter of ∼4.4 nm [38]. (3) 2D nanomaterials based on Pd have high\nphotothermal stability upon NIR irradiation. For instance, the sheet-like structure of Pd@Ag nanoplates as well as their surface plasmon resonance (SPR) absorption in NIR region were well retained after exposure to 808-nm laser at 2 W for 30 min, whereas silver nanoprisms were severely distorted under the same irradiation [36]. (4) Besides their function as effective photothermal contrast agents for PTT and PTTbased combined therapy, Pd-based 2D nanomaterials readily act as contrast agents for cancer PA or CT imaging. (5) They typically exhibit excellent biocompability both in vitro and in vivo. Due to these remarkable properties, the bioapplications of 2D Pdbased nanomaterials have been widely explored since they were first synthesized by our group [5] in 2011.\nIn this review, we will first summarize the synthesis and optical properties of Pdbased 2D nanomaterials. Recent advances of the 2D Pd-based nanomaterials in cancer theranostics including imaging, PTT and PTT-based combined therapy are then discussed. Moreover, the biosafety of these nanomaterials is assessed. Finally, perspectives on major challenges and future opportunities of 2D nanomaterials based on Pd are underlined."
    }, {
      "heading" : "2 Synthesis of 2D Pd-based nanomaterials",
      "text" : "2.1 Synthesis of Pd nanosheets (Pd NSs)\nWiley Online Library. (d) Representative TEM images of Pd@Ag nanoplates. Modified with permission from Ref. [36], Copyright 2011, Wiley Online Library. (e) Representative TEM images of Pd mesocrystalline nanocorolla. Reproduced with permission from Ref. [46], Copyright 2011, American Chemical Society.\n2.2 Synthesis of Pd@M (M=Au and Ag) bimetallic nanoplates\nNoble metals, including Au and Ag, are readily epitaxially deposited on the surface of Pd NSs to form the well-defined core-shell Pd@M nanostructures (Fig. 1a) [36, 45, 47]. Typically, uniform hexagonal Pd NSs were first synthesized and used as seeds for the growth of Au or Ag thereon to produce the core-shell nanoplates. The growth of Au or Ag on Pd NSs was achieved by chemically reducing AuPPh3Cl with hydrazine hydrate in DMF (Fig. 1c) [45] or reducing AgNO3 with formaldehyde [36] or H2 [47] in an aqueous solution respectively (Fig. 1d). The thickness of Au or Ag layer on Pd NSs can be fine-tuned by changing the amount of Au or Ag precursor. It should be noted that the growth of Ag on Pd NSs proceeded from the uniform deposition of Ag overlayer on Pd NSs. By contrast, the coating of Au on Pd NSs grew gradually from the edges towards the center."
    }, {
      "heading" : "2.3 Synthesis of mesocrystalline Pd nanocorolla",
      "text" : "The corolla-like Pd mesocrystallites composed of interconnected ultrathin Pd NSs\n(∼1.8 nm) were synthesized by an etching growth strategy under CO confinement (Fig. 1a, e) [46]. The preparation procedure of Pd nanocorolla is similar to that of Pd NSs except the addition of FeCl3 as etching agent. The co-presence of CO and Fe 3+ was critical to the synthesis of the branched corolla-like Pd mesocrystallites. While the existence of CO makes it possible for anisotropic growth of the 1.8 nm-thick Pd NSs as branches, Fe 3+ etches the Pd seeds at the early reaction stage, resulting in the formation of the branched structure."
    }, {
      "heading" : "3 Optical properties of 2D Pd-based nanomaterials",
      "text" : "A common remarkable property of these Pd-based 2D nanomaterials is that they exhibit size- or thickness-dependent surface plasmon resonance (SPR) absorption. For instance, with the increase of edge length from 21 to 27, 41 and 51 nm, the SPR peak of the Pd NSs was red-shifted from 826 to 992, and from 1,045 to 1,068 nm, respectively (Fig. 2a) [5, 37]. What is more, the maximum optical absorption of\nPd@Ag nanoplates was blue-shifted from 971 nm to 812, 710, 602, 529 and 477 nm as the thickness of Pd@Ag nanoplates raised from 3.5 to 5.4, 6.9, 14.1, and 19.8 nm, respectively (Fig. 2b) [36, 37]. Similarly, different sizes of Pd@Au nanoplates also showed tunable optical spectra in NIR region [45].\nThe ultrathin sheet-like feature with the thickness fixed at ∼1.8 nm is essential to\nthe unique SPR property of Pd NSs, which has been confirmed by the calculation of extinction spectra using the discrete dipole approximation (DDA) method. Pd NSs exhibited strong absorption in the NIR region. The extinction coefficient of 41 nm Pd NSs was measured to be 4.1×10 9 L/(mol cm) at 1,045 nm, comparable to that of Au nanorods. Unlike pure Au or Ag nanostructures that display NIR absorption, Pd NSs showed an excellent stability upon NIR laser irradiation [48]. Significantly enhanced stability under laser irradiation was also observed for Pd@Ag nanoplates (Fig. 2c) compared to pure Ag nanoprisms which was destroyed under the same irradiation (Fig. 2d) [36, 37]."
    }, {
      "heading" : "4 Application of 2D Pd-based nanomaterials in imaging and therapy",
      "text" : "4.1 Contrast agents for imaging\nPhotoacoustic (PA) imaging, as a noninvasive imaging modality, has recently attracted increasing interests in biomedical fields [49-53]. In this technique, endogenous or exogenous PA contrast agents can absorb pulsed laser energy and convert it into heat, resulting in thermal expansion of the air that surrounds the contrast agents and creates acoustic waves for imaging [50, 51]. Currently, due to the weak optical absorption of most endogenous PA contrast agents, tremendous effort has been devoted to the development of exogenous PA imaging agents for better contrast effect and detection depth. Nanomaterials with NIR absorption such as organic dye-based nanoparticles, polymer-based nanoparticles, carbon-based nanomaterials and metallic nanomaterials have great potential as exogenous contrast agents for PA imaging [49-58]. Among them, Au nanostructures have been extensively investigated [51, 56], however, the anisotropic gold nanostructures can be easily destroyed by laser irradiation. On the other hand, 2D Pd-based nanomaterials are ideal candidates as a new class of exogenous PA contrast agents for PA imaging because of their strong absorption in NIR region, high photothermal stability, and good tumor accumulation capability. Nie et al. [48] have demonstrated the application of Pd NSs as contrast agents for in vivo PA imaging. After intravenous administration of Pd NSs into tumor-bearing mice, significant and long-lasting PA contrast-enhanced signals in tumor sites were obtained under 790 nm laser irradiation (4 mJ/cm2). By contrast, the PBS-injected mice only manifested the PA signals of tumor skin owing to the low absorption contrast of tumor. It is worth noting that Pd NSs showed good biocompatibility both in cells and mice. Co-culture cells with Pd NSs at a relative high concentration didn’t affect the cell viability. Moreover the histological examination of mice injected with Pd NSs for 7 days did not show obvious side effect either. In a further investigation from our group, bimetallic Pd@Au-PEG nanoplates were also successfully used as a PA contrast agent to achieve high-quality imaging of tumor sites (Fig. 3a) [45].\nX-ray computed tomography (CT) is one of the most frequently used diagnostic tools in hospitals [59, 60]. Because of their high X-ray absorption, good biocompatibility as well as easy surface functionalization [60], Au nanoparticles have been extensively investigated as CT contrast agents. The application of the bimetallic Pd@Au-PEG nanoplates as CT contrast agent was also assessed. It was found that the intensity of the CT signal increased with the increasing concentration of Au and the tumor site showed an obvious enhancement with a significantly higher CT value after 24 h injection of Pd@Au-PEG nanoplates (Fig. 3b) [45].\nBesides the application of inherent nature of Pd-based nanomaterials, surface modification with other imaging agents provided us more opportunities to understand their in vivo behaviors. For instance, by conjugating Gd chelates on the surface of Pd NSs, the real-time in vivo distribution of Pd NSs was monitored [61]."
    }, {
      "heading" : "4.2 2D Pd-based nanomaterials in cancer therapy",
      "text" : ""
    }, {
      "heading" : "4.2.1 Photothermal therapy (PTT)",
      "text" : "As mentioned above, 2D Pd-based nanomaterials exhibited great potential in PTT because of their strong NIR absorption and excellent photothermal stability. In 2011, our group [5] first reported the application of Pd NSs in cancer PTT. It was found that the temperature of 1 mL 27 µg/mL Pd NSs aqueous solution could rise from 28.0 to\n48.7 ºC after 10 min under 808 nm laser irradiation with a power density of 1 W/cm2. By incubating liver cancer cells with polyethyleneimine-modified Pd NSs for 12 h, ∼100% of the cells were killed after 5 min of laser irradiation (808 nm, 1.4 W/cm 2 ).\nThe ultrathin feature of Pd NSs is unique, but weakens their cellular uptake efficiency when used in PTT. To increase the uptake efficacy of Pd NSs, silica coating was employed to increase the thickness of Pd NSs, and amino groups were also modified on the surface of silica [62]. A 13-fold increase of the cellular uptake of Pd NSs was achieved compared to unmodified Pd NSs. As a result, the photothermal cell-killing efficacy was significantly improved. Almost 100% of the cells incubated with Pd@Silica-NH2 were killed after 2 min irradiation, while only half of the cells were killed for unmodified Pd NSs.\nThe first application of Pd NSs in in vivo PTT appeared in 2014 [38]. Ultra-small Pd NSs about 4.4 nm in diameter were successfully synthesized and modified with reduced glutathione (GSH). Compared with large Pd NSs, ultra-small Pd NSs showed higher photothermal conversion efficiency, and the in vivo behaviors of Pd-GSH were well investigated on tumor-bearing mice after intravenous injection (Fig. 4). Compared with unmodified Pd NSs, Pd NSs modified with glutathione exhibited a remarkable longer blood circulation. Their accumulation in tumor was also increased.\nWith the use of glutathione-modified Pd NSs, upon 808 nm laser irradiation, tumors were completely ablated. Together with their excellent photothermal conversion efficiency at NIR region, their high tumor accumulation performance makes these ultrasmall Pd NSs with great potentials for application in photothermal cancer therapy.\nCore-shell bimetallic Pd@Ag, Pd@Au nanoplates and mesocrystalline Pd nanocorolla have also been used in in vitro and in vivo cancer PTT [36, 45, 47, 63- 65]. We systemically evaluated the in vivo NIR PTT efficacy of Pd@Au nanoplates\nwith a mean diameter of ∼30 nm and an average thickness of ∼4 nm. After surface modification with PEG-SH, the as-prepared Pd@Au-PEG nanoplates were intravenously injected into 4T1 tumor-bearing Balb/c mice. It was surprising that the\naccumulation of Pd@Au-PEG nanoplates in tumor sites was able to achieve ∼79%\nID/g at 24 h post injection. It was demonstrated that the surface PEGylation and the unique two-dimensional structural feature of Pd@Au nanoplates might contribute to their enhanced passive accumulation in tumor sites. As a result of the high accumulation, PTT was carried out at a lower 808 nm laser power density of 0.5 W/cm 2 . The tumors were completely destroyed after 4-min irradiation, and no tumor regrowth was observed over a course of 60 d [45]. Moreover, as compared to singledomain Pd NSs, the mesocrystalline Pd nanocorolla also exhibited higher cancer cells killing efficiency due to the increased apparent thickness that allowed them to be taken up by cells more easily than the ultrathin Pd NSs [47].\nOverall, the unique optical properties, high photothermal conversion efficiency and stability, along with the excellent biocompatibility of Pd-based 2D nanomaterials make them potential candidate in cancer PTT, which has been demonstrated by in vitro and in vivo studies."
    }, {
      "heading" : "4.2.2 Combination therapy of cancer",
      "text" : "Although significant progress has been made in the NIR PTT, several disadvantages still limit their potential clinical application [29, 66]. For example, the small spot size produced by laser restricts the therapeutic area of cancer tissue. Relatively high laser power (for instance, 2–4 W/cm2 for gold nanomaterials) is often\nused for obtaining sufficient heat to kill cancer cells [67, 68]. Owing to their low-level renal clearance and high accumulation in some reticuloendothelial system (RES)\norgans (e.g., liver, spleen) after systematic administration, NIR photothermal nanomaterials may induce potential toxicity [69].\nTo overcome the limitations of currently available NIR photothermal therapeutic systems as well as take advantages of different treatment modalities, combination therapy has emerged in recent years [70-76]. Compared with single treatment, combined therapy exhibits remarkable synergistic or collaborative effect, and conquers the defect of single treatment mode, therefore can achieve better therapeutic efficacy [72, 75]. Here, we summarized the combination therapy applications of 2D Pd-based nanomaterials in PTT-chemotherapy [64, 65, 77, 78] and PTTphotodynamic therapy (PDT) [63, 79, 80]."
    }, {
      "heading" : "4.2.2.1 PTT-chemotherapy combined therapy",
      "text" : "Current clinical treatment investigation has shown that hyperthermia can promote the delivery of drug into tumor [81-83], resulting in additionally enhanced anticancer effect. Like most nanocarriers, 2D Pd-based nanomaterials can also serve as drug delivery platform due to their large surface area, good biocompatibility and facile surface-functionalization. Moreover, the application of laser irradiation not only triggers the release of drug molecules in a controllable manner, but also improves the cell-killing efficiency. Consequently, the integration of PTT and chemotherapy on 2D Pd-based nanomaterials should achieve good synergistic effects.\nFang et al. [64] developed novel mesoporous silica-coated Pd@Ag nanoplates (Pd@Ag@sSiO2@mSiO2-DOX) as a multifunctional therapeutic system (Fig. 5). In the synthesized composite, bimetallic Pd@Ag nanoplate core can effectively convert the absorbed NIR light energy into heat, and the outer mesoporous SiO2 shell provides high surface area for anticancer drug DOX loading. Moreover, DOX molecules are bound to the mesoporous shell through coordination bonds that are sensitive to pH and heat. Thus, the release of DOX from the core-shell delivery vehicles into cancer cells can be triggered by the acidic pH in endosome and NIR laser. As expected, the release of DOX from Pd@Ag@sSiO2@mSiO2-DOX showed pH-dependent manner and the exposure of carrier to 808 nm laser irradiation (1 W) significantly increased the release rate of DOX. Cytotoxicity assay indicated that the cell-killing efficacy for the combination of Pd@Ag@sSiO2@mSiO2-DOX and laser irradiation was higher than the total of chemotherapy by DOX-loaded particles and\nphotothermal therapy by Pd@Ag@sSiO2@mSiO2 without DOX, showing an outstanding synergistic effect of chemotherapy and photothermal treatment.\nAnother multifunctional nanosystem integrating PTT and chemotherapy based on 2D Pd-based nanomaterials was also reported by Tang et al. [78]. In this system,\nDOX was directly loaded on the surface of ∼4.4 nm small Pd NSs through Pd-N coordination bonding. Then Pd-DOX was modified by reduced glutathione (GSH). Tissue distribution measured by ICP-MS demonstrated that Pd–DOX–GSH accumulated in tumors higher than Pd-GSH after 24 h post injection, indicating that DOX could enhance the accumulation of Pd-GSH nanomaterials in tumors. In vivo experimental results showed that mice treated with Pd-DOX-GSH and laser irradiation (the combination of chemotherapy and PTT) resulted in better therapeutic effects than those treated with Pd-GSH (PTT) or Pd-DOX-GSH (chemotherapy) alone. The synergistic effect yielded effective anticancer therapy with both lower chemical drug doses and lower NIR laser power. More importantly, Pd-DOX–GSH hybrid nanoparticles could be cleared from the body through the renal system into the urine because of their small size."
    }, {
      "heading" : "4.2.2.2 PTT-photodynamic combined therapy",
      "text" : "Photodynamic therapy (PDT) is another light-based technique for cancer therapy [84, 85]. In this technique, photosensitizer (PS) molecules were first irradiated by a suitable wavelength laser, then the activated PS interacts with molecular oxygen to\ngenerate reactive oxygen species to destroy cancer cells irreversibly [84, 85]. However, the application of many PSs in clinic has been impeded by their hydrophobicity and easy aggregation in aqueous solution that greatly reduced PDT efficacy. To overcome the drawbacks and improve the PDT therapeutic efficiency, different strategies, such as loading PSs on various nanocarriers [75, 86-88] and the combination of PDT with other treatment modalities (e.g., chemotherapy, PTT) have been developed [75]. By utilizing some near-infrared absorption photothermal nanomaterials, such as Au and carbon nanostructures, as the carriers of PSs, high synergistic therapeutic effect has been achieved by the combination of PDT and PTT [75].\nRecently, we developed mesoporous silica-coated Pd@Ag nanoparticles (Pd@Ag@mSiO2) as an excellent nanoplatform for PS delivery [63]. In this architecture, photosensitizer chlorin e6 (Ce6) were covalently conjugated to the mesoporous shell, preventing them from being degraded or prematurely released into the systemic circulation. The prepared Pd@Ag@mSiO2-Ce6 nanoparticles displayed good water solubility as well as high efficiency in photo-generating cytotoxic singlet oxygen. More importantly, the good photothermal effects of Pd@Ag nanoplates under NIR irradiation could be utilized to enhance the cell uptake of Ce6. Using confocal fluorescence imaging, brighter fluorescence was observed after laser irradiation inside the cells than that without irradiation, indicating more nanoparticles were taken up by the cells. Flow cytometry experiments further confirmed that 808 nm laser irradiation can increase the fluorescence of Ce6 1.3 times greater than the cells incubation with nanoparticles without irradiation. These results indicated that moderate temperature rise caused by Pd@Ag@mSiO2-Ce6 nanoparticles under NIR light irradiation could increase cell membrane permeability and led to the improved cellular uptake of nanoparticles, greatly enhancing the toxicity of nanoparticles and causing more cell death than only PDT. The PTT/PDT combined therapy effects were also demonstrated in vivo with satisfactory results.\nAlthough excellent therapeutic indexes have been achieved via PTT/PDT synergistic effects in most of the studies, the use of two different wavelength lasers to excite PDT and PTT separately will complicate the treatment process due to the absorption mismatch of photothermal agents and PSs at NIR region [33, 89].\nTo perform PTT/PDT simultaneous treatments upon a single laser, we prepared Ce6-functionalized Pd NSs (Pd-PEI-Ce6) [79]. To synthesize Pd-PEI-Ce6, Ce6 was\nfirstly conjugated to polyethylenimine (PEI), then the prepared Ce6-PEI was loaded onto small Pd NSs via electrostatic and coordination interaction (Fig. 6a). Pd-PEI-Ce6 had following merits: (1) The maximum absorption wavelength of small Pd NSs and Ce6 was about 660 nm in the NIR region. Laser at this wavelength alone should excite PDT and PTT simultaneously, simplifying the experimental procedure. (2) Excellent singlet oxygen generation capacity, high photothermal conversion efficiency and good biocompatibility, would benefit the in vivo treatment application. With these advantages, the photothermal-photodynamic combination therapy was successfully performed both in vitro and in vivo, demonstrating greater treatment effects than PTT using Pd NSs or PDT using Ce6 alone (Fig. 6b, c). This work highlights the potential of Pd NSs for multimode cancer therapies.\nFig. 6 (Color online) (a) Fabrication and PTT/PDT combined treatment applications of Pd-PEI-Ce6 nanocomposite. (b) Fluorescence images of HeLa cells incubated with Ce6, Pd-PEI nanosheets and Pd-PEI-Ce6 for 12 h under irradiation of 660 nm laser (0.5 W/cm2) for 5 min. The cells were stained with propidium iodide (PI). (c) Relative tumor volume of S180 tumors in different groups of mice upon treatment with 660 nm laser (0.5 W/cm2) for 5 min. Reproduced with permission from Ref. [79], Copyright 2014, American Chemical Society."
    }, {
      "heading" : "5 Biosafety of 2D Pd-based nanomaterials",
      "text" : "Although 2D nanomaterials have demonstrated wide application prospects in nanomedicine, their biosafety assessments, including pharmacokinetics, biodistribution, biodegradation, excretion and potential toxicity et al, are still in infancy and require further investigation [3]. Pd-based 2D nanomaterials, with welldefined shape and controlled size, can be used as a model system to systematically study the biosafety of 2D nanomaterials. Based on this, we conducted a series of work in cells and animal modes [5, 36, 38, 45, 47, 62-65, 77-80, 90, 91]. No obvious toxicity was observed in vitro and in vivo levels, indicating good biocompatibility of\nthese 2D Pd-based nanomaterials.\nFor clinical applications, the nanomaterial-based diagnostic or therapeutic agents should be effectively degraded or eliminated out of body after finishing their functions [92-95] to decrease the likelihood of unintended acute or chronic toxicity [93]. Noble metal nanomaterials are typically difficult to be degraded in vivo. However, we have found that GSH-modified small Pd NSs (∼4.4 nm in diameter)\nwere clearable from body through the renal excretion route into urine [38]. In this case, both small sizes and GSH coating contributed to the gradual clearance of PdGSH from body. Considering the function of GSH, we further tested the clearance effects of GSH on different surface-modified small Pd NSs (e.g., Pd-PVP, PdPEG(SH)). It was found that the injection of GSH solution effectively increased the clearance of different surface-modified Pd NSs (Fig. 7) [90]. In addition, blood biochemistry and histological examinations also indicated that small Pd NSs did not induce appreciable toxicity to the treated mice. These observations not only suggest that small Pd NSs have relatively high biosafety and hold great potentials for clinical theranostic application, but also provide a new method for promoting the metabolism of other nanoparticles from body. More recently, we systematically investigated the influence of surface modifications on the in vivo behaviors of small Pd NSs [91]. Among the studied coating molecules (i.e., carboxymethyl chitosan, PEG-NH2, PEGSH and dihydrolipoic acid-zwitterion), PEG-SH-coated Pd NSs have the longest blood circulation half-life and also the highest accumulation in tumor. Moreover, Pd NSs with different sizes (i.e., 5, 13, 30, and 80 nm) were also assessed recently for their size-dependent biosafety, such as biodistribution, toxicity and genomic gene expression profiles. Results indicated that size had an important influence on the biological behaviors of Pd NSs [96]. These studies are expected to promote the applications of 2D Pd-based and other nanomaterials in nanomedicines.\nFig. 7 (Color online) GSH accelerating the metabolism of different surface-modified small Pd NSs [90]."
    }, {
      "heading" : "6 Conclusion and prospects",
      "text" : "As an important branch of noble metal nanostructures, 2D Pd-based nanomaterials have recently attracted increasing interests for applications in biomedical field. We summarized in this review the synthesis, properties, biosafety and applications of these 2D Pd-based nanomaterials for cancer imaging, photothermal therapy, and combination therapy. These Pd-based 2D nanomaterials with well-defined shapes and controlled sizes show excellent photothermal conversion efficiency and also photothermal stability, making them as excellent NIR agents for cancer PTT. Based on their large surface area, anticancer drugs or photosensitizers are readily loaded onto these Pd nanomaterials to offer the combination of PTT/chemotherapy and PTT/PDT with enhanced therapeutic effects. In addition, due to their strong absorption in NIR region, these Pd-based nanomaterials can realize imaging (e.g., PA, CT)-guided PTT for cancer treatment.\nAlthough considerable research progresses have been made on the applications of Pd-based 2D nanomaterials in bioimaging and cancer therapy, the following aspects are still needed to be further explored for promoting the clinical translation of these 2D nanosystems:\n(1) As demonstrated in our previous work, the sizes and surface coatings have important influences on the biological behaviors and treatment outcomes of 2D Pdbased nanomaterials [38, 90, 91]. To further improve the treatment efficacy as well as biosafety of 2D Pd-based nanomaterials in nanomedicine, it is highly desire to systematically investigate deeply the effects of other factors, including shapes,\ncomposition, charge, thickness and so on, on the in vivo behaviors of Pd-based nanomaterials.\n(2) To further expand the applications of Pd-based 2D nanomaterials in nanomedicines, new theranostic functionalities based on these materials should be explored. More imaging and therapeutic modalities, such as radioactive iodine-based SPECT/CT imaging and radiotherapy, can be integrated into these 2D materials to achieve multimode imaging-guided therapy as well as enhanced therapeutic efficacies.\n(3) Considering the accumulation of 2D Pd-based nanomaterials in tumors mainly depends on the passive targeting (EPR effects) in most previous work, some targeting molecules (e.g., antibodies, nucleic acid aptamers, small targeting biomolecules) may be modified on the surface of these nanomaterials to further improve their accumulation in tumors via active targeting.\n(4) So far, research results indicated that Pd-based nanomaterials had no obvious toxic effects on either cultured cells or living animals for a short term. The potential long-term in vivo toxicities of Pd-based nanomaterials should be systematically evaluated before their future clinical applications.\n(5) Pd-based nanomaterials have exhibited good biocompatibility and therapeutic effects in mouse tumor models. In order to push their clinical translational applications, the biological behaviors of 2D Pd-based nanomaterials in more tumor model systems (e.g., on rat, rabbit) should be further explored.\nWe hope this review will encourage the development of other 2D nanomaterials for\nclinical applications."
    }, {
      "heading" : "Acknowledgments",
      "text" : "The work was supported by the National Natural Science Foundation of China (21101131, 21420102001), the National Basic Research Program of China (2014CB932004), and Natural Science Foundation of Fujian Province (2016J01073). We thank Dr. Binghui Wu for help with the language correction.\nConflict of interest The authors declare that they have no conflict of interest.\nReferences\n1. Shi JJ, Kantoff PW, Wooster R et al (2017) Cancer nanomedicine: progress, challenges and\nopportunities. Nat Rev Cancer 17: 20–37\n2. Yang K, Feng L, Shi X et al (2013) Nano-graphene in biomedicine: theranostic applications. Chem\nSoc Rev 42: 530-547\n3. Chen Y, Wang L, Shi J (2016) Two-dimensional non-carbonaceous materials-enabled efficient\nphotothermal cancer therapy. Nano Today 11: 292-308\n4. Lin J, Chen X, Huang P (2016) Graphene-based nanomaterials for bioimaging. Adv Drug Deliver\nRev 105: 242-254\n5. Huang XQ, Tang SH, Mu XL et al (2011) Freestanding palladium nanosheets with plasmonic and\ncatalytic properties. Nat Nanotechnol 6: 28-32\n6. Liu T, Wang C, Gu X et al (2014) Drug delivery with PEGylated MoS2 nano-sheets for combined\nphotothermal and chemotherapy of cancer. Adv Mater 26: 3433-3440\n7. Li J, Jiang F, Yang B et al (2013) Topological insulator bismuth selenide as a theranostic platform\nfor simultaneous cancer imaging and therapy. Sci Rep 3:1998\n8. Song G, Hao J, Liang C et al (2016) Degradable molybdenum oxide nanosheets with rapid clearance\nand efficient tumor homing capabilities as a therapeutic nanoplatform. Angew Chem Int Ed 55: 2122-2126 9. Lin J, Wang M, Hu H et al (2016) Multimodal-imaging-guided cancer phototherapy by versatile\nbiomimetic theranostics with UV and γ-irradiation protection. Adv Mater 28: 3273–3279\n10. Moon HK, Lee SH, Choi HC (2009) In vivo near-infrared mediated tumor destruction by\nphotothermal effect of carbon nanotubes. ACS Nano 3: 3707-3713\n11. Huang X, El-Sayed IH, Qian W et al (2006) Cancer cell imaging and photothermal therapy in the\nnear-infrared region by using gold nanorods. J Am Chem Soc 128: 2115-2120\n12. Robinson JT, Tabakman SM, Liang Y et al (2011) Ultrasmall reduced graphene oxide with high\nnear-infrared absorbance for photothermal therapy. J Am Chem Soc 133: 6825-6831\n13. Loo C, Lowery A, Halas N et al (2005) Immunotargeted nanoshells for integrated cancer imaging\nand therapy. Nano Lett 5: 709-711\n14. Yang K, Zhang S, Zhang G et al (2010) Graphene in mice: ultrahigh in vivo tumor uptake and\nefficient photothermal therapy. Nano Lett 10: 3318-3323\n15. Hirsch LR, Stafford RJ, Bankson JA et al (2003) Nanoshell-mediated near-infrared thermal therapy\nof tumors under magnetic resonance guidance. Proc Natl Acad Sci USA 100: 13549-13554\n16. Yuan H, Fales AM, Vo-Dinh T (2012) Tat peptide-functionalized gold nanostars: enhanced\nintracellular delivery and efficient NIR photothermal therapy using ultralow irradiance. J Am Chem Soc 134:11358-11361 17. Zhang Z, Wang J, Nie X et al (2014) Near infrared laser-induced targeted cancer therapy using\nthermoresponsive polymer encapsulated gold nanorods. J Am Chem Soc 136: 7317-7326\n18. Bardhan R, Chen W, Perez-Torres C et al (2009) Nanoshells with targeted simultaneous\nenhancement of magnetic and optical imaging and photothermal therapeutic response. Adv Funct Mater 19: 3901-3909\n19. Wu L, Fang S, Shi S et al (2013) Hybrid polypeptide micelles loading indocyanine green for tumor\nimaging and photothermal effect study. Biomacromolecules 14: 3027-3033\n20.Jian WH, Yu TW, Chen CJ et al (2015) Indocyanine green-encapsulated hybrid polymeric\nnanomicelles for photothermal cancer therapy. Langmuir 31: 6202-6210\n21. Huang P, Gao Y, Lin J et al (2015) Tumor-specific formation of enzyme-instructed supramolecular\nself-assemblies as cancer theranostics. ACS Nano 9: 9517-9527\n22. Liu X, Tao H, Yang K et al (2011) Optimization of surface chemistry on single-walled carbon\nnanotubes for in vivo photothermal ablation of tumors. Biomaterials 32: 144-151\n23. Chakravarty P, Marches R, Zimmerman NS et al (2008) Thermal ablation of tumor cells with\nantibody-functionalized single-walled carbon nanotubes. Proc Natl Acad Sci USA 105: 8697-8702\n24. Huang N, Wang H, Zhao J et al (2010) Single-wall carbon nanotubes assisted photothermal cancer\ntherapy: animal study with a murine model of squamous cell carcinoma. Laser Surg Med 42: 638- 648 25. Chen D, Wang C, Nie X et al (2014) Photoacoustic imaging guided near-infrared photothermal\ntherapy using highly water-dispersible single-walled carbon nanohorns as theranostic agents. Adv Funct Mater 24: 6621-6628 26. Feng L, Li K, Shi X et al (2014) Smart pH-responsive nanocarriers based on nano-graphene oxide\nfor combined chemo- and photothermal therapy overcoming drug resistance. Adv Healthcare Mater 3: 1261-1271 27. Lin J, Wang S, Huang P et al (2013) Photosensitizer-loaded gold vesicles with strong plasmonic\ncoupling effect for imaging-guided photothermal/photodynamic therapy. ACS Nano 7: 5320-5329\n28. Dreaden EC, Mackey MA, Huang X et al (2011) Beating cancer in multiple ways using nanogold.\nChem Soc Rev 40: 3391-3404\n29. Terentyuk G, Panfilova E, Khanadeev V et al (2014) Gold nanorods with a hematoporphyrin-\nloaded silica shell for dual-modality photodynamic and photothermal treatment of tumors in vivo. Nano Res 7: 325-337 30. Bardhan R, Lal S, Joshi A et al (2011) Theranostic nanoshells: from probe design to imaging and\ntreatment of cancer. Acc Chem Res 44: 936-946\n31. Khan SA, Kanchanapally R, Fan Z et al (2012) A gold nanocage-cnt hybrid for targeted imaging\nand photothermal destruction of cancer cells. Chem Commun 48: 6711-6713\n32. Yavuz MS, Cheng Y, Chen J et al (2009) Gold nanocages covered by smart polymers for controlled\nrelease with near-infrared light. Nat Mater 8: 935-939\n33. Jang B, Park JY, Tung CH et al (2011) Gold nanorod-photosensitizer complex for near-infrared\nfluorescence imaging and photodynamic/photothermal therapy in vivo. ACS Nano 5: 1086-1094\n34. Kuo WS, Chang CN, Chang YT et al (2010) Gold nanorods in photodynamic therapy, as\nhyperthermia agents, and in near-infrared optical imaging. Angew Chem Int Ed 49: 2711-2715\n35. Akchurin G, Khlebtsov B, Tuchin V et al (2008) Gold nanoshell photomodification under a single-\nnanosecond laser pulse accompanied by color-shifting and bubble formation phenomena. Nanotechnology 19: 015701\n36. Huang XQ, Tang SH, Liu BJ et al (2011) Enhancing the photothermal stability of plasmonic metal\nnanoplates by a core-shell architecture. Adv Mater 23: 3420-3425\n37. Chen M, Wu BH, Yang J et al (2012) Small adsorbate-assisted shape control of Pd and Pt\nnanocrystals. Adv Mater 24: 862-879\n38. Tang SH, Chen M, Zheng NF (2014) Sub-10-nm Pd nanosheets with renal clearance for efficient\nnear-infrared photothermal cancer therapy. Small 10: 3139-3144\n39. Tian QW, Tang MH, Sun YG et al (2011) Hydrophilic flower-like CuS superstructures as an effi\ncient 980 nm laser-driven photothermal agent for ablation of cancer cells. Adv. Mater. 23: 3542– 3547 40. Bu X, Zhou D, Li J et al (2014) Copper sulfide self-assembly architectures with improved\nphotothermal performance. Langmuir 30: 1416-1423\n41. Huang YZ, Lai YL, Shi SG et al (2015) Copper sulfide nanoparticles with phospholipid-PEG\ncoating for in vivo near-infrared photothermal cancer therapy. Chem Asian J 10: 370-376.\n42. Wang Z, Huang P, Jacobson O et al (2016) Biomineralization-inspired synthesis of copper sulfide–\nferritin nanocages as cancer theranostics. ACS Nano 10: 3453-3460\n43. Zamiri R, Zakaria A, Husin MS et al (2011) Formation of silver microbelt structures by laser\nirradiation of silver nanoparticles in ethanol. Int J Nanomed 6: 2221-2224\n44. Li H, Chen G, Yang H et al (2013) Shape-controlled synthesis of surface-clean ultrathin palladium\nnanosheets by simply mixing a dinuclear Pd(I) carbonyl chloride complex with H2O. Angew Chem Int Ed 52: 8368-8372 45. Chen M, Tang SH, Guo ZD et al (2014) Core-shell Pd@Au nanoplates as theranostic agents for in-\nvivo photoacoustic imaging, CT imaging, and photothermal therapy. Adv Mater 26: 8210-8216\n46. Wang XL, Wu BH, Chen GX et al (2014) A hydride-induced reduction strategy for fabricating\npalladium-based core-shell bimetallic nanocrystals. Nanoscale 6: 6798-6804\n47. Huang XQ, Tang SH, Yang J et al (2011) Etching growth under surface confinement: an effective\nstrategy to prepare mesocrystalline Pd nanocorolla. J Am Chem Soc 133: 15946-15949\n48. Nie LM, Chen M, Sun XL et al (2014) Palladium nanosheets as highly stable and effective contrast\nagents for in vivo photoacoustic molecular imaging. Nanoscale 6: 1271-1276\n49. Wang S, Lin J, Wang T et al (2016) Recent advances in photoacoustic imaging for deep-tissue\nbiomedical applications. Theranostics 6: 2394-2413\n50. De La Zerda A, Zavaleta C, Keren S et al (2008) Carbon nanotubes as photoacoustic molecular\nimaging agents in living mice. Nat Nanotechnol 3: 557-562\n51. Mallidi S, Larson T, Tam J et al (2009) Multiwavelength photoacoustic imaging and plasmon\nresonance coupling of gold nanoparticles for selective detection of cancer. Nano Lett 9:2825-2831 52. Chen YS, Frey W, Kim S et al (2011) Silica-coated gold nanorods as photoacoustic signal\nnanoamplifiers. Nano Lett 11: 348-354\n53. Melancon MP, Zhou MIN, Li C (2011) Cancer theranostics with near-infrared light-activatable\nmultimodal nanoparticles. Acc Chem Res 44: 947-956\n54. Pu K, Shuhendler AJ, Jokerst JV et al (2014) Semiconducting polymer nanoparticles as\nphotoacoustic molecular imaging probes in living mice. Nat Nanotechnol 9: 233-239\n55. Zerda A, Liu Z, Bodapati S et al (2010) Ultrahigh sensitivity carbon nanotube agents for\nphotoacoustic molecular imaging in living mice. Nano Lett 10: 2168-2172\n56. Moon GD, Choi SW, Cai X et al (2011) A new theranostic system based on gold nanocages and\nphase-change materials with unique features for photoacoustic imaging and controlled release. J Am Chem Soc 133: 4762-4765 57. Cheng L, Liu J, Gu X et al (2014) Pegylated WS2 nanosheets as a multifunctional theranostic agent\nfor in vivo dual-modal CT/photoacoustic imaging guided photothermal therapy. Adv Mater 26: 1886-1893 58. Zerda A, Bodapati S, Teed R et al (2012) Family of enhanced photoacoustic imaging agents for\nhigh-sensitivity and multiplexing studies in living mice. ACS Nano 6: 4694-4701\n59. Cheon J, Lee JH (2008) Synergistically integrated nanoparticles as multimodal probes for\nnanobiotechnology. Acc Chem Res 41: 1630-1640\n60. Alric C, Taleb J, Duc GL et al (2008) Gadolinium chelate coated gold nanoparticles as contrast\nagents for both x-ray computed tomography and magnetic resonance imaging. J Am Chem Soc 130: 5908-5915 61. Zhu X, Chi X, Chen J et al (2015) Real-time monitoring in vivo behaviors of theranostic\nnanoparticles by contrast-enhanced T1 imaging. Anal Chem 87: 8941-8948\n62. Tang SH, Huang XQ, Zheng NF (2011) Silica coating improves the efficacy of Pd nanosheets for\nphotothermal therapy of cancer cells using near infrared laser. Chem Commun 47: 3948-3950\n63. Shi S, Zhu X, Zhao Z et al (2013) Photothermally enhanced photodynamic therapy based on\nmesoporous Pd@Ag@mSiO2 nanocarriers. J Mater Chem B 1: 1133-1141\n64. Fang WJ, Yang J, Gong JW et al (2012) Photo- and pH-triggered release of anticancer drugs from\nmesoporous silica-coated Pd@Ag nanoparticles. Adv Funct Mater 22: 842-848\n65. Shi SG, Chen XL, Wei JP et al (2016) Platinum(IV) prodrug conjugated Pd@Au nanoplates for\nchemotherapy and photothermal therapy. Nanoscale 8: 5706-5713\n66. Von Maltzahn G, Park JH, Agrawal A et al (2009) Computationally guided photothermal tumor\ntherapy using long-circulating gold nanorod antennas. Cancer Res 69: 3892-3900\n67. Dickerson EB, Dreaden EC, Huang X et al (2008) Gold nanorod assisted near-infrared plasmonic\nphotothermal therapy (PPTT) of squamous cell carcinoma in mice. Cancer Lett 269: 57-66\n68. Chen J, Wang D, Xi J et al (2007) Immuno gold nanocages with tailored optical properties for\ntargeted photothermal destruction of cancer cells. Nano Lett 7: 1318-1322\n69. O’Neal DP, Hirsch LR, Halas NJ et al (2004) Photo-thermal tumor ablation in mice using near\ninfrared-absorbing nanoparticles. Cancer Lett 209: 171-176\n70. Fang S, Lin J, Li C et al (2016) Dual-stimuli responsive nanotheranostics for multimodal imaging\nguided trimodal synergistic therapy. Small DOI: 10.1002/smll.201602580\n71. Wang Y, Wang K, Zhao J et al (2013) Multifunctional mesoporous silica-coated graphene\nnanosheet used for chemo-photothermal synergistic targeted therapy of glioma. J Am Chem Soc 135: 4799-4804 72. Zhang W, Guo Z, Huang D et al (2011) Synergistic effect of chemo-photothermal therapy using\npegylated graphene oxide. Biomaterials 32: 8555-8561\n73. Park H, Yang J, Lee J et al (2009) Multifunctional nanoparticles for combined doxorubicin and\nphotothermal treatments. ACS Nano 3: 2919-2926\n74.Yan X, Hu H, Lin J et al (2015) Optical and photoacoustic dual-modality imaging guided\nsynergistic photodynamic/photothermal therapies. Nanoscale 7: 2520-2526\n75. Zhang M, Murakami T, Ajima K et al (2008) Fabrication of ZnPc/protein nanohorns for double\nphotodynamic and hyperthermic cancer phototherapy. Proc Natl Acad Sci USA105: 14773-14778\n76. Li J, Zhao Y (2016) Nanotechnology in the programmed cell therapy: nowhere to escape of cancer.\nSci Bull 1: 45-47\n77. Fang WJ, Tang SH, Liu PX et al (2012), Pd nanosheet-covered hollow mesoporous silica\nnanoparticles as a platform for the chemo-photothermal treatment of cancer cells. Small 8: 3816- 3822 78. Tang SH, Chen M, Zheng NF (2015) Multifunctional ultrasmall Pd nanosheets for enhanced near-\ninfrared photothermal therapy and chemotherapy of cancer. Nano Res 8: 165-174\n79. Zhao ZX, Shi SG, Huang YZ et al (2014) Simultaneous photodynamic and photothermal therapy\nusing photosensitizer-functionalized pd nanosheets by single continuous wave laser. ACS Appl Mater Interfaces 6: 8878-8885 80. Zhao ZX, Huang YZ, Shi SG et al (2014) Cancer therapy improvement with mesoporous silica\nnanoparticles combining photodynamic and photothermal therapy. Nanotechnology 25: 285701\n81. Zhang Z, Wang J, Chen C (2013) Near-infrared light-mediated nanoplatforms for cancer thermo-\nchemotherapy and optical imaging. Adv Mater 25: 3869-3880\n82. Yang HW, Lu YJ, Lin KJ et al (2013) EGRF conjugated pegylated nanographene oxide for targeted\nchemotherapy and photothermal therapy. Biomaterials 34: 7204-7214\n83. Yin W, Yan L, Yu J et al (2014) High-throughput synthesis of single-layer MoS2 nanosheets as a\nnear-infrared photothermal-triggered drug delivery for effective cancer therapy. ACS Nano 8: 6922-6933 84. Castano AP, Mroz P, Hamblin MR (2006) Photodynamic therapy and anti-tumour immunity. Nat\nRev Cancer 6: 535-545\n85. Hamblin MR, Hasan T (2004) Photodynamic therapy: a new antimicrobial approach to infectious\ndisease? Photochem Photobiol Sci 3: 436-450\n86. Mroz P, Sharma SK, Zhiyentayev T et al (2011) Photodynamic therapy: photosensitizer targeting\nand delivery. In: Kratz F, Senter P, Steinhagen H, editors. Drug delivery in oncology: from basic research to cancer therapy. Weinheim:Wiley-VCH; p. 1569-1603 87. Wang S, Huang P, Nie L et al (2013) Single continuous wave laser induced\nphotodynamic/plasmonic photothermal therapy using photosensitizer-functionalized gold nanostars. Adv Mater 25: 3055-3061\n88. Fan W, Huang P, Chen X (2016) Overcoming the Achilles’ heel of photodynamic therapy. Chem\nSoc Rev 45: 6488-6519\n89. Wang J, Zhu G, You M et al (2012) Assembly of aptamer switch probes and photosensitizer on\ngold nanorods for targeted photothermal and photodynamic cancer therapy. ACS Nano 6: 5070- 5077\n90. Huang YZ, Chen XL, Shi SG et al (2015) Effect of glutathione on in vivo biodistribution and\nclearance of surface-modified small Pd nanosheets. Sci China Chem 11: 1753-1758\n91. Shi SG, Huang YZ, Chen XL et al (2015) Optimization of surface coating on small Pd nanosheets\nfor in vivo near-infrared photothermal therapy of tumor. ACS Appl Mater Interfaces 7: 14369- 14375 92. Longmire M, Choyke PL, Kobayashi H (2008) Clearance properties of nano-sized particles and\nmolecules as imaging agents: Considerations and caveats. Nanomedicine 3: 703-717\n93. Choi HS, Liu W, Misra P et al (2007) Renal clearance of quantum dots. Nat Biotechnol 25: 1165-\n1170\n94. Zhou C, Long M, Qin Y et al (2011) Luminescent gold nanoparticles with efficient renal clearance.\nAngew Chem Int Ed 50: 3168-3172\n95. Liu J, Yu M, Zhou C et al (2013) Passive tumor targeting of renal-clearable luminescent gold\nnanoparticles: Long tumor retention and fast normal tissue clearance. J Am Chem Soc 135: 4978- 4981 96. Chen M, Chen SZ, He CY et al (2016) Safety profile of two-dimensional Pd nanosheets for\nphotothermal therapy and photoacoustic imaging. Nano Res DOI 10.1007/s12274-016-1349-6"
    } ],
    "references" : [ {
      "title" : "Cancer nanomedicine: progress, challenges and opportunities",
      "author" : [ "JJ Shi", "PW Kantoff", "R Wooster" ],
      "venue" : "Nat Rev Cancer",
      "citeRegEx" : "1",
      "shortCiteRegEx" : "1",
      "year" : 2017
    }, {
      "title" : "Nano-graphene in biomedicine: theranostic applications",
      "author" : [ "K Yang", "L Feng", "X Shi" ],
      "venue" : "Chem Soc Rev",
      "citeRegEx" : "2",
      "shortCiteRegEx" : "2",
      "year" : 2013
    }, {
      "title" : "Two-dimensional non-carbonaceous materials-enabled efficient photothermal cancer therapy",
      "author" : [ "Y Chen", "L Wang", "J Shi" ],
      "venue" : "Nano Today",
      "citeRegEx" : "3",
      "shortCiteRegEx" : "3",
      "year" : 2016
    }, {
      "title" : "Graphene-based nanomaterials for bioimaging",
      "author" : [ "J Lin", "X Chen", "P Huang" ],
      "venue" : "Adv Drug Deliver Rev",
      "citeRegEx" : "4",
      "shortCiteRegEx" : "4",
      "year" : 2016
    }, {
      "title" : "Freestanding palladium nanosheets with plasmonic and catalytic properties",
      "author" : [ "XQ Huang", "SH Tang", "XL Mu" ],
      "venue" : "Nat Nanotechnol",
      "citeRegEx" : "5",
      "shortCiteRegEx" : "5",
      "year" : 2011
    }, {
      "title" : "Drug delivery with PEGylated MoS2 nano-sheets for combined photothermal and chemotherapy of cancer",
      "author" : [ "T Liu", "C Wang", "X Gu" ],
      "venue" : "Adv Mater",
      "citeRegEx" : "6",
      "shortCiteRegEx" : "6",
      "year" : 2014
    }, {
      "title" : "Topological insulator bismuth selenide as a theranostic platform for simultaneous cancer imaging and therapy",
      "author" : [ "J Li", "F Jiang", "B Yang" ],
      "venue" : null,
      "citeRegEx" : "7",
      "shortCiteRegEx" : "7",
      "year" : 2013
    }, {
      "title" : "Degradable molybdenum oxide nanosheets with rapid clearance and efficient tumor homing capabilities as a therapeutic nanoplatform",
      "author" : [ "G Song", "J Hao", "C Liang" ],
      "venue" : "Angew Chem Int Ed",
      "citeRegEx" : "8",
      "shortCiteRegEx" : "8",
      "year" : 2016
    }, {
      "title" : "2016) Multimodal-imaging-guided cancer phototherapy by versatile biomimetic theranostics with UV and γ-irradiation protection",
      "author" : [ "J Lin", "M Wang", "H Hu" ],
      "venue" : "Adv Mater",
      "citeRegEx" : "9",
      "shortCiteRegEx" : "9",
      "year" : 2016
    }, {
      "title" : "In vivo near-infrared mediated tumor destruction by photothermal effect of carbon nanotubes",
      "author" : [ "HK Moon", "SH Lee", "HC Choi" ],
      "venue" : "ACS Nano",
      "citeRegEx" : "10",
      "shortCiteRegEx" : "10",
      "year" : 2009
    }, {
      "title" : "Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods",
      "author" : [ "X Huang", "IH El-Sayed", "W Qian" ],
      "venue" : "J Am Chem Soc",
      "citeRegEx" : "11",
      "shortCiteRegEx" : "11",
      "year" : 2006
    }, {
      "title" : "Ultrasmall reduced graphene oxide with high near-infrared absorbance for photothermal therapy",
      "author" : [ "JT Robinson", "SM Tabakman", "Y Liang" ],
      "venue" : "J Am Chem Soc",
      "citeRegEx" : "12",
      "shortCiteRegEx" : "12",
      "year" : 2011
    }, {
      "title" : "Immunotargeted nanoshells for integrated cancer imaging and therapy",
      "author" : [ "C Loo", "A Lowery", "N Halas" ],
      "venue" : "Nano Lett",
      "citeRegEx" : "13",
      "shortCiteRegEx" : "13",
      "year" : 2005
    }, {
      "title" : "Graphene in mice: ultrahigh in vivo tumor uptake and efficient photothermal therapy",
      "author" : [ "K Yang", "S Zhang", "G Zhang" ],
      "venue" : "Nano Lett",
      "citeRegEx" : "14",
      "shortCiteRegEx" : "14",
      "year" : 2010
    }, {
      "title" : "Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance",
      "author" : [ "LR Hirsch", "RJ Stafford", "JA Bankson" ],
      "venue" : "Proc Natl Acad Sci USA",
      "citeRegEx" : "15",
      "shortCiteRegEx" : "15",
      "year" : 2003
    }, {
      "title" : "Tat peptide-functionalized gold nanostars: enhanced intracellular delivery and efficient NIR photothermal therapy using ultralow irradiance",
      "author" : [ "H Yuan", "AM Fales", "T Vo-Dinh" ],
      "venue" : "J Am Chem Soc 134:11358-11361",
      "citeRegEx" : "16",
      "shortCiteRegEx" : "16",
      "year" : 2012
    }, {
      "title" : "Near infrared laser-induced targeted cancer therapy using thermoresponsive polymer encapsulated gold nanorods",
      "author" : [ "Z Zhang", "J Wang", "X Nie" ],
      "venue" : "J Am Chem Soc",
      "citeRegEx" : "17",
      "shortCiteRegEx" : "17",
      "year" : 2014
    }, {
      "title" : "Nanoshells with targeted simultaneous enhancement of magnetic and optical imaging and photothermal therapeutic response",
      "author" : [ "R Bardhan", "W Chen", "C Perez-Torres" ],
      "venue" : "Adv Funct Mater",
      "citeRegEx" : "18",
      "shortCiteRegEx" : "18",
      "year" : 2009
    } ],
    "referenceMentions" : [ {
      "referenceID" : 0,
      "context" : "With the development of nanotechnology, the application of nanomaterials for drug delivery, cancer diagnosis and therapy has attracted great attention [1].",
      "startOffset" : 151,
      "endOffset" : 154
    }, {
      "referenceID" : 1,
      "context" : ", MoS2 and Bi2Se3) with high surface area, strong near-infrared (NIR) light absorption and good biocompatibility have been applied to photothermal therapy and other biomedical fields [2-4, 6, 7].",
      "startOffset" : 183,
      "endOffset" : 194
    }, {
      "referenceID" : 2,
      "context" : ", MoS2 and Bi2Se3) with high surface area, strong near-infrared (NIR) light absorption and good biocompatibility have been applied to photothermal therapy and other biomedical fields [2-4, 6, 7].",
      "startOffset" : 183,
      "endOffset" : 194
    }, {
      "referenceID" : 3,
      "context" : ", MoS2 and Bi2Se3) with high surface area, strong near-infrared (NIR) light absorption and good biocompatibility have been applied to photothermal therapy and other biomedical fields [2-4, 6, 7].",
      "startOffset" : 183,
      "endOffset" : 194
    }, {
      "referenceID" : 5,
      "context" : ", MoS2 and Bi2Se3) with high surface area, strong near-infrared (NIR) light absorption and good biocompatibility have been applied to photothermal therapy and other biomedical fields [2-4, 6, 7].",
      "startOffset" : 183,
      "endOffset" : 194
    }, {
      "referenceID" : 6,
      "context" : ", MoS2 and Bi2Se3) with high surface area, strong near-infrared (NIR) light absorption and good biocompatibility have been applied to photothermal therapy and other biomedical fields [2-4, 6, 7].",
      "startOffset" : 183,
      "endOffset" : 194
    }, {
      "referenceID" : 8,
      "context" : "Photothermal therapy (PTT), in which light energy is converted into thermal energy by light-absorbing agents for destroying cancer cells, has recently emerged as a new candidate technique for cancer treatment [9-15].",
      "startOffset" : 209,
      "endOffset" : 215
    }, {
      "referenceID" : 9,
      "context" : "Photothermal therapy (PTT), in which light energy is converted into thermal energy by light-absorbing agents for destroying cancer cells, has recently emerged as a new candidate technique for cancer treatment [9-15].",
      "startOffset" : 209,
      "endOffset" : 215
    }, {
      "referenceID" : 10,
      "context" : "Photothermal therapy (PTT), in which light energy is converted into thermal energy by light-absorbing agents for destroying cancer cells, has recently emerged as a new candidate technique for cancer treatment [9-15].",
      "startOffset" : 209,
      "endOffset" : 215
    }, {
      "referenceID" : 11,
      "context" : "Photothermal therapy (PTT), in which light energy is converted into thermal energy by light-absorbing agents for destroying cancer cells, has recently emerged as a new candidate technique for cancer treatment [9-15].",
      "startOffset" : 209,
      "endOffset" : 215
    }, {
      "referenceID" : 12,
      "context" : "Photothermal therapy (PTT), in which light energy is converted into thermal energy by light-absorbing agents for destroying cancer cells, has recently emerged as a new candidate technique for cancer treatment [9-15].",
      "startOffset" : 209,
      "endOffset" : 215
    }, {
      "referenceID" : 13,
      "context" : "Photothermal therapy (PTT), in which light energy is converted into thermal energy by light-absorbing agents for destroying cancer cells, has recently emerged as a new candidate technique for cancer treatment [9-15].",
      "startOffset" : 209,
      "endOffset" : 215
    }, {
      "referenceID" : 14,
      "context" : "Photothermal therapy (PTT), in which light energy is converted into thermal energy by light-absorbing agents for destroying cancer cells, has recently emerged as a new candidate technique for cancer treatment [9-15].",
      "startOffset" : 209,
      "endOffset" : 215
    }, {
      "referenceID" : 17,
      "context" : ", indocyanine green (ICG) dye) [18-21], carbon-based nanomaterials (e.",
      "startOffset" : 31,
      "endOffset" : 38
    }, {
      "referenceID" : 5,
      "context" : ", Au or Pdbased nanomaterials) [27-38], copper chalcogenide semiconductors [39-42] and transition metal dichalcogenides mentioned above [6, 7], have been explored for photothermal ablation of cancer.",
      "startOffset" : 136,
      "endOffset" : 142
    }, {
      "referenceID" : 6,
      "context" : ", Au or Pdbased nanomaterials) [27-38], copper chalcogenide semiconductors [39-42] and transition metal dichalcogenides mentioned above [6, 7], have been explored for photothermal ablation of cancer.",
      "startOffset" : 136,
      "endOffset" : 142
    }, {
      "referenceID" : 4,
      "context" : "[5], Copyright 2011, Nature Publishing Group.",
      "startOffset" : 0,
      "endOffset" : 3
    }, {
      "referenceID" : 4,
      "context" : "our group [5] first reported the application of Pd NSs in cancer PTT.",
      "startOffset" : 10,
      "endOffset" : 13
    }, {
      "referenceID" : 2,
      "context" : "Although 2D nanomaterials have demonstrated wide application prospects in nanomedicine, their biosafety assessments, including pharmacokinetics, biodistribution, biodegradation, excretion and potential toxicity et al, are still in infancy and require further investigation [3].",
      "startOffset" : 273,
      "endOffset" : 276
    }, {
      "referenceID" : 4,
      "context" : "Based on this, we conducted a series of work in cells and animal modes [5, 36, 38, 45, 47, 62-65, 77-80, 90, 91].",
      "startOffset" : 71,
      "endOffset" : 112
    } ],
    "year" : 2017,
    "abstractText" : "Noble metal nanomaterials have been extensively explored in cancer diagnostic and therapeutic applications owing to their unique physical and chemical properties, such as facile synthesis, straightforward surface functionalization, strong photothermal effect, and excellent biocompatibility. Herein, we summarize the recent development of two-dimensional (2D) Pd-based nanomaterials and their applications in cancer diagnosis and therapy. Different synthetic strategies for Pd nanosheets and the related nanostructures, including Pd@Au, Pd@Ag nanoplates and mesocrystalline Pd nanocorolla, are first discussed. Together with their unique properties, the potential bioapplications of these 2D Pd nanomaterials are then demonstrated. With strong absorption in near-infrared (NIR) region, these nanomaterials have great potentials in cancer photothermal therapy (PTT). They also readily act as contrast agents in photoacoustic (PA) imaging or X-ray computed tomography (CT) to achieve imageguided cancer therapy. Moreover, significant efforts have been devoted to studying the combination of PTT and other treatment modalities (e.g., chemotherapy or photodynamic therapy) based on Pd nanomaterials. The remarkable synergistic or collaborative effects to achieve better therapeutic efficacy are discussed as well. Additionally, the biosafety of 2D Pd-based nanomaterials in vitro and in vivo was evaluated. Finally, challenges for the applications of Pd-based nanomaterials in cancer diagnosis and therapy, and future research prospects are highlighted.",
    "creator" : "Elsevier"
  }
}